Fate Therapeutics Inc
FATE
Revenue
6.77M
▲4.85M▲251.79%
3 Months ChangeAssets
528.82M
▼-41.08M▼-7.21%
3 Months ChangeLiabilities
131.84M
▼-11.94M▼-8.31%
3 Months ChangeFree Cash Flow
-33.44M
▼-1.37M▼-4.27%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-30
Form 8-K
ID: 0001193125-24-211130
2024-08-13
Form 10-Q
ID: 0000950170-24-096187
2024-08-13
Form 8-K
ID: 0000950170-24-096177
2024-07-31
Form 8-K
ID: 0001193125-24-189911
2024-06-10
Form 8-K
ID: 0001193125-24-158374
2024-06-07
Form 8-K
ID: 0001193125-24-157554
2024-05-31
Form 8-K
ID: 0001193125-24-151963
2024-05-09
Form 10-Q
ID: 0000950170-24-056869
2024-05-09
Form 8-K
ID: 0000950170-24-056852
2024-05-09
Form 8-K
ID: 0001193125-24-134840